Get started
NNN

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

NSB chart


Full chart

Key stats


Market capitalization
‪5.64 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
17.727
Basic EPS (TTM)
0.002 AUD
Net income (FY)
‪324.21 K‬ AUD
Revenue (FY)
0.00 AUD
Shares float
—
Beta (1Y)
−0.31

About NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD


Sector
Health Technology
Industry
Biotechnology
Headquarters
Cottesloe
Website
neuroscientific.com
Founded
2002
ISIN
AU0000012973
FIGI
BBG00KW6L6T8
Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. It's research and development program is focused on developing a treatment for stroke-related brain injury and dementia or Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The company was founded by William Harold Clough on November 14, 2002 and is headquartered in Nedlands, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NSB news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NSB is 0.036 AUD — it has decreased by −7.69% in the past 24 hours. Watch NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stocks are traded under the ticker NSB.
NSB stock hasn't changed in a week, the month change is a −10.00% fall, over the last year NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD has showed a −40.00% decrease.
NSB reached its all-time high on Sep 27, 2021 with the price of 0.540 AUD, and its all-time low was 0.033 AUD and was reached on Oct 1, 2024. View more price dynamics on NSB chart.
See other stocks reaching their highest and lowest prices.
NSB stock is 0.00% volatile and has beta coefficient of −0.31. Track NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD there?
Yes, you can track NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
NSB net income for the last half-year is ‪1.55 M‬ AUD, while the previous report showed ‪−1.23 M‬ AUD of net income which accounts for 226.36% change. Track more NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD financial stats to get the full picture.
No, NSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD stock shows the sell signal. See more of NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.